Prebiotics: Germinated barley foodstuff for the prevention of colitis-associated colon cancer?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 8, 2011, Pages 1219-1220

  Koh, Seong Joon ^a   Kim, Joo Sung ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PREBIOTIC AGENT;

BARLEY; BIFIDOBACTERIUM ANIMALIS; CANCER PREVENTION; COLITIS; COLON CANCER; EDITORIAL; ENTERITIS; EUBACTERIUM; HUMAN; INTESTINE FLORA; LACTOBACILLUS; NONHUMAN; PRIORITY JOURNAL;

EID: 79960472985     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06769.x     Document Type: Editorial

References (20)

1. Potack J, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease. Gut Liver 2008; 2: 61-73.
2. Sellon RK, Tonkonogy S, Schultz M etal. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 1998; 66: 5224-31.
3. Dieleman LA, Hoentjen F, Qian BF etal. Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats. Clin. Exp. Immunol. 2004; 136: 30-9.
4. Swidsinski A, Ladhoff A, Pernthaler A etal. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002; 122: 44-54.
5. Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis in inflammatory bowel disease. Gut 2004; 53: 1-4.
6. Sokol H, Seksik P, Rigottier-Gois L etal. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm. Bowel Dis. 2006; 12: 106-11.
7. Garcia Vilela E, De Lourdes De Abreu Ferrari M, Oswaldo Da Gama Torres H etal. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scand. J. Gastroenterol. 2008; 43: 842-8.
8. Uronis JM, Muhlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS ONE 2009; 4: e6026.
9. Othman M, Aguero R, Lin HC. Alterations in intestinal microbial flora and human disease. Curr. Opin. Gastroenterol. 2008; 24: 11-16.
10. Kim SW, Kim HM, Yang KM etal. Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice. Inflamm. Bowel Dis. 2010; 16: 1514-25.
11. Lim CC, Ferguson LR, Tannock GW. Dietary fibres as "prebiotics": implications for colorectal cancer. Mol. Nutr. Food Res. 2005; 49: 609-19.
12. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004; 126: 1620-33.
13. Kanauchi O, Nakamura T, Agata K, Mitsuyama K, Iwanaga T. Effects of germinated barley foodstuff on dextran sulfate sodium-induced colitis in rats. J. Gastroenterol. 1998; 33: 179-88.
14. Araki Y, Andoh A, Koyama S, Fujiyama Y, Kanauchi O, Bamba T. Effects of germinated barley foodstuff on microflora and short chain fatty acid production in dextran sulfate sodium-induced colitis in rats. Biosci. Biotechnol. Biochem. 2000; 64: 1794-800.
15. Kanauchi O, Suga T, Tochihara M etal. Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial. J. Gastroenterol. 2002; 37 (Suppl. 14): 67-72.
16. Kanauchi O, Mitsuyama K, Andoh A, Iwanaga T. Modulation of intestinal environment by prebiotic germinated barley foodstuff prevents chemo-induced colonic carcinogenesis in rats. Oncol. Rep. 2008; 20: 793-801.
17. Komiyama Y, Mitsuyama K, Masuda J etal. Prebiotic treatment in experimental colitis reduces the risk of colitic cancer. J. Gastroenterol. Hepatol. 2011; 26: 1298-308.
18. Shinozaki M, Watanabe T, Kubota Y, Sawada T, Nagawa H, Muto T. High proliferative activity is associated with dysplasia in ulcerative colitis. Dis. Colon Rectum 2000; 43: S34-9.
19. Sokol H, Pigneur B, Watterlot L etal. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA 2008; 105: 16731-6.
20. O'Hara AM, Shanahan F. Mechanisms of action of probiotics in intestinal diseases. ScientificWorldJournal 2007; 7: 31-46.